医疗器材销售协议（2016-2026）

医疗器材产业全球销售合作展望

本报告 "医疗器材销售协议趋势" 对全球医疗器材产业的销售合作进行了全面分析。报告专为业务拓展、授权和商业策略专业人士设计，深入剖析了企业如何制定销售协议、协商财务条款以及透过策略合作拓展市场。

这份经过全面修订和更新的报告分析了2016年至2026年间签订的销售协议，清楚地展示了医疗器材製造商如何与销售合作伙伴携手合作，加速新市场开发和商业化进程。

本报告包​​含一份完整的销售协议清单，该清单已在 "当前协议" 交易和合作资料库中註册，并提供指向可用财务条款和线上交易记录的连结。对于已公开备案的协议，本报告还提供向美国证券交易委员会 (SEC) 提交的底层合约文件的存取权限，从而深入了解销售合作关係的实际建构方式。

无论您是进行交易结构基准分析、寻找销售合作伙伴，还是开展商业化战略尽职调查，本报告都能提供您所需的真实交易数据和合同信息，助您构建更强大的销售协议。

主要优势

• 显着缩短研究时间

无需搜寻多份新闻稿、资料库和监管文件，即可存取统一的销售交易资料库。

• 销售协议结构基准分析

了解医疗器材公司如何建构其销售合作关係，包括地域权、商业化责任和营运角色。

• 财务合约分析条款

审查已揭露的付款结构和商业条款，并对类似销售合作关係的财务结构进行基准分析。

• 查阅实际合约文件

在条件允许的情况下，查阅已向美国证券交易委员会 (SEC) 提交的销售协议，以深入了解实际合作关係背后的详细合约条款。

• 识别最活跃的销售合作伙伴

识别医疗器材产业销售合作关係中的关键参与者，并分析其商业化策略。

• 追踪产业趋势

依公司、治疗领域和技术领域分析自 2016 年以来的销售协议趋势，以了解医疗器材商业化策略的演变。

回报内容

2016 年以来销售交易趋势分析

销售合作关係结构与财务模型概述

基于已揭露资讯的主要销售协议审查金额

销售协议中最活跃公司简介

依公司、治疗领域和技术类型分类的交易详细分析

协议资料库中已註册的销售协议的最新综合目录。

线上交易记录和合约文件连结（如有）

基于实际合约的尽职调查洞察

本报告分析了实际的销售协议，使用户能够评估关键的合作条款，例如：

• 地域销售权
• 合作伙伴之间的商业责任
• 付款结构与商业条款
• 独家销售条款
• 供应与销售义务
• 合约期限和终止条款
• 本报告的重要性
• 销售合作关係对于医疗器材的全球商业化至关重要。它们使公司能够扩大市场覆盖范围、加速产品上市并获得区域专业知识。
• 透过结合全面的交易数据、财务基准和实际合约文件，本报告提供了建立更强大的销售合作关係和更有效地进行谈判所需的洞察。

目录

摘要整理

第一章：引言

第二章：销售交易趋势

• 引言
• 销售协议的定义
• 2016年以来的销售协议趋势
  • 依年份划分的销售交易
  • 依研发阶段划分的销售交易
  • 依治疗领域划分的销售交易
  • 依科技划分的销售交易
  • 以最活跃公司划分的销售交易
  • 纯粹销售交易的特征
  • 多组件交易中的销售特征
• 协调合作伙伴以确保销售协议有效运作

第三章 - 销售协议概述架构

• 引言
• 销售协议结构
• 作为更广泛合作协议一部分的销售权

第四章 - 主要销售协议

• 引言
• 以价值为排名的顶级销售交易

第五章 - 最活跃的25家经销商

• 引言
• 最活跃的25家经销商
• 交易目录
• 依公司（AZ）划分的销售交易目录
• 依治疗领域划分的销售交易目录
• 以技术类型划分的销售交易目录
• 关于研究公司
• 当前合作伙伴关係
• 当前协议
• 近期合作报告标题

Benchmark Global Distribution Partnerships Across the Medical Device Industry

This latest Distribution Deals in Medical Devices report provides a comprehensive analysis of distribution partnerships across the global medical device sector. Designed for business development, licensing, and commercial strategy professionals, the report delivers detailed insight into how companies structure distribution agreements, negotiate financial terms, and expand market access through strategic partnerships.

Fully revised and updated, the report examines distribution deals announced between 2016 and 2026, providing a clear view of how device manufacturers collaborate with distribution partners to reach new markets and accelerate commercialization.

The report contains a comprehensive listing of distribution deals recorded in the Current Agreements deals and alliances database, including financial terms where available and links to online deal records. Where agreements have been publicly filed, the report also provides access to the underlying contract documents submitted to the SEC, enabling deeper insight into how distribution partnerships are structured in practice.

Whether you are benchmarking deal structures, identifying distribution partners, or performing due diligence on commercialization strategies, this report provides the real-world deal data and contract intelligence needed to structure stronger distribution agreements.

Key Benefits

• Save Significant Research Time

Access a consolidated database of distribution deals instead of searching multiple press releases, databases, and regulatory filings.

• Benchmark Distribution Deal Structures

Understand how medical device companies structure distribution partnerships, including territorial rights, commercialization responsibilities, and operational roles.

• Analyze Financial Deal Terms

Review disclosed payment structures and commercial terms to benchmark the financial structure of comparable distribution partnerships.

• Access Real Contract Documents

Where available, explore SEC-filed distribution agreements, providing insight into the detailed contractual provisions behind real-world partnerships.

• Identify the Most Active Distribution Dealmakers

Discover which companies are leading distribution partnerships across the medical device sector and analyze their commercialization strategies.

• Track Industry Trends

Analyze distribution deal activity since 2016 across companies, therapeutic areas, and technology segments to understand how device commercialization strategies are evolving.

What's Included in the Report

Analysis of distribution dealmaking trends since 2016

Overview of distribution partnership structures and financial models

Review of leading distribution deals by disclosed value

Profiles of the most active distribution dealmakers

Detailed analysis of deals organized by company, therapeutic area, and technology type

A comprehensive directory of distribution deals recorded in the Current Agreements database

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual distribution contracts, the report allows users to evaluate key partnership provisions such as:

• Territorial distribution rights
• Commercial responsibilities between partners
• Payment structures and commercial terms
• Exclusivity provisions
• Supply and commercialization obligations
• Contract duration and termination provisions
• Why This Report Matters
• Distribution partnerships are critical to the global commercialization of medical devices, enabling companies to expand market reach, accelerate product launches, and access regional expertise.
• By combining comprehensive deal data, financial benchmarking, and access to real contract documents, this report provides the intelligence needed to structure stronger distribution partnerships and negotiate more effectively.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deal
• 2.3. Trends in distribution deals since 2016
  • 2.3.1. Distribution dealmaking by year
  • 2.3.2. Distribution dealmaking by phase of development
  • 2.3.3. Distribution dealmaking by therapy area
  • 2.3.4. Distribution dealmaking by technology type
  • 2.3.5. Distribution dealmaking by most active company
  • 2.3.6 Attributes of pure distribution deals
  • 2.3.7 Attributes of distribution in multi-component deals
• 2.4. Aligning partners to make the distribution agreement work

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure
• 3.3 Distribution rights as part of a wider alliance agreement

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements
• Figure 3: Distribution deals signed at each phase of development
• Figure 4: Distribution deals by therapy area
• Figure 5: Distribution deals by technology type
• Figure 6: Top 25 most active distribution dealmakers
• Figure 7: Issues in implementing distribution agreements
• Figure 8: Distribution agreements - what should a contract include?
• Figure 9: Components of the distribution deal structure
• Figure 10: Top distribution deals by value
• Figure 11: Most active distribution dealmakers